Industry

NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 at 12:30 p.m. ET. Company management will also participate in one-on-one meetings during the conference, which will … [Read more…]

NATICK, Mass.–(BUSINESS WIRE)–Pillar Biosciences, the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) products and technologies to localize testing and reduce time to treatment initiation and overall testing costs, today announced that Randy Pritchard, Chief Executive Officer, will participate in the “Liquid Biopsy in Clinical Practice” panel discussion at the 2022 UBS … [Read more…]

Net sales of $118.1 million, a decrease of 3% on a reported basis and flat on a constant currency basis over prior year Global Orthopedics net sales growth of 11% on a constant currency basis driven by new products and channel investments GAAP EPS of $0.12 and adjusted EPS of $0.08 Executed partnership with CGBio … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Neurovascular Thrombectomy Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The model discusses in detail the impact of COVID-19 on Neurovascular Thrombectomy Devices market for the year 2020 and beyond. Neurovascular thrombectomy devices … [Read more…]

Extension allows for satisfaction of the HSR Condition as outlined in the Merger Agreement Epizyme stockholders are encouraged to tender their shares to the offer today PARIS–(BUSINESS WIRE)–Regulatory News: Ipsen S.A. (Euronext: IPN; ADR: IPSEY) today announced that Hibernia Merger Sub, Inc. (Purchaser), its wholly owned indirect subsidiary, has extended the expiration time for the … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its supplemental New Drug Application (sNDA) for NUPLAZID® (pimavanserin) for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). The CRL indicated that the … [Read more…]

 An innovative and cost-effective alternative to traditional staffing firms, the flipMD Hire platform allows healthcare companies to now recruit for full-time and temporary physician positions, in addition to consulting opportunities PHILADELPHIA–(BUSINESS WIRE)–Please replace the release dated August 3, 2022 with the following corrected version due to multiple revisions. The updated release reads: FLIPMD LAUNCHES NEW … [Read more…]

AHF thanks U.S. President Joe Biden for proclaiming a national state of emergency on monkeypox earlier today; urges federal government to immediately allocate money, staff and resources nationally LOS ANGELES–(BUSINESS WIRE)–AIDS Healthcare Foundation (AHF) commended President Joseph Biden for proclaiming a national state of emergency on monkeypox earlier today. The move comes as more than … [Read more…]

RICHMOND, Va.–(BUSINESS WIRE)–McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Center (NACHC) National Health Center Week 2022 (NHCW) on Aug. 7-13. The theme of NHCW 2022 is “Community Health Centers: The Chemistry for Strong Communities.” As a strong supporter of the nation’s … [Read more…]

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) [(“Merrimack” or the “Company”)] today announced its second quarter 2022 financial results for the period ended June 30, 2022. “We are pleased to report continued reductions in operating expenses as we remain focused on conserving cash to ensure that we have sufficient financial resources to capture future potential … [Read more…]